Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Sigma A6730 | 3.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | M-CSF | 366.0 | 65 | |
RA2159 | JNK-IN-8 | 3.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | M-CSF | 267.0 | 67 | |
RA2159 | JNK-IN-11 | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | M-CSF | 318.0 | 65 | |
RA2159 | Lestaurtinib | 0.3 | uM | 2 | M-CSF | 120.0 | 58 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 2 | M-CSF | 490.0 | 77 | ||||
N2586 | EO1428 | 1.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | M-CSF | 537.0 | 50 | |
N2586 | PI103 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 2 | M-CSF | 463.0 | 82 | |
N2586 | Sigma A6730 | 3.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | M-CSF | 480.0 | 53 | |
N2586 | JNK-IN-8 | 3.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | M-CSF | 403.0 | 63 | |
N2586 | JNK-IN-11 | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | M-CSF | 382.0 | 56 | |
N2586 | Lestaurtinib | 0.3 | uM | 2 | M-CSF | 152.5 | 76 | ||||
RA2159 | IL-6 | 100 | ug/mL | 2 | M-CSF | 203.0 | 72 | ||||
RA2159 | EO1428 | 1.0 | uM | IL-6 | 100 | ug/mL | 2 | M-CSF | 130.0 | 68 | |
RA2159 | PI103 | 0.1 | uM | IL-6 | 100 | ug/mL | 2 | M-CSF | 192.0 | 77 | |
RA2159 | Sigma A6730 | 3.0 | uM | IL-6 | 100 | ug/mL | 2 | M-CSF | 140.0 | 63 | |
RA2159 | JNK-IN-8 | 3.0 | uM | IL-6 | 100 | ug/mL | 2 | M-CSF | 120.0 | 73 | |
RA2159 | JNK-IN-11 | 0.3 | uM | IL-6 | 100 | ug/mL | 2 | M-CSF | 130.5 | 38 | |
RA2159 | Ruxolitinib | 0.3 | uM | 2 | M-CSF | 150.5 | 58 | ||||
N2586 | IL-6 | 100 | ug/mL | 2 | M-CSF | 190.5 | 74 | ||||
N2586 | EO1428 | 1.0 | uM | IL-6 | 100 | ug/mL | 2 | M-CSF | 224.5 | 66 | |
N2586 | PI103 | 0.1 | uM | IL-6 | 100 | ug/mL | 2 | M-CSF | 182.0 | 83 | |
N2586 | Sigma A6730 | 3.0 | uM | IL-6 | 100 | ug/mL | 2 | M-CSF | 184.0 | 81 | |
N2586 | JNK-IN-8 | 3.0 | uM | IL-6 | 100 | ug/mL | 2 | M-CSF | 143.0 | 72 | |
N2586 | JNK-IN-11 | 0.3 | uM | IL-6 | 100 | ug/mL | 2 | M-CSF | 139.0 | 59 | |
N2586 | Ruxolitinib | 0.3 | uM | 2 | M-CSF | 201.0 | 51 |